
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A bibliometric analysis of PROTAC from 2001 to 2021
Deping Li, Dongmin Yu, Yan Li, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114838-114838
Closed Access | Times Cited: 66
Deping Li, Dongmin Yu, Yan Li, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114838-114838
Closed Access | Times Cited: 66
Showing 1-25 of 66 citing articles:
A Journey of Challenges and Victories: A Bibliometric Worldview of Nanomedicine since the 21st Century
Jingyu Wang, Wenling Zhao, Zhao Zhang, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 39
Jingyu Wang, Wenling Zhao, Zhao Zhang, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 39
Research in the Field of Drug Design and Development
Grażyna Biała, Ewa Kędzierska, Marta Kruk-Słomka, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1283-1283
Open Access | Times Cited: 27
Grażyna Biała, Ewa Kędzierska, Marta Kruk-Słomka, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1283-1283
Open Access | Times Cited: 27
PROTACs: Novel tools for improving immunotherapy in cancer
Shizhe Li, Ting Chen, Jinxin Liu, et al.
Cancer Letters (2023) Vol. 560, pp. 216128-216128
Closed Access | Times Cited: 25
Shizhe Li, Ting Chen, Jinxin Liu, et al.
Cancer Letters (2023) Vol. 560, pp. 216128-216128
Closed Access | Times Cited: 25
PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 25
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 25
Novel approaches to targeted protein degradation technologies in drug discovery
Yu Xue, Andrew A. Bolinger, Jia Zhou
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 4, pp. 467-483
Closed Access | Times Cited: 23
Yu Xue, Andrew A. Bolinger, Jia Zhou
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 4, pp. 467-483
Closed Access | Times Cited: 23
Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity
Jenny Desantis, Alessandro Bazzacco, Michela Eleuteri, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116202-116202
Open Access | Times Cited: 11
Jenny Desantis, Alessandro Bazzacco, Michela Eleuteri, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116202-116202
Open Access | Times Cited: 11
Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapy
Lu-Qi Cao, Haidong Sun, Yuhao Xie, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Lu-Qi Cao, Haidong Sun, Yuhao Xie, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases
Yi‐Ru Bai, Weiguang Yang, Xuehui Hou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115606-115606
Closed Access | Times Cited: 20
Yi‐Ru Bai, Weiguang Yang, Xuehui Hou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115606-115606
Closed Access | Times Cited: 20
Progress in the controllability technology of PROTAC
Xin He, Zhibing Weng, Yi Zou
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116096-116096
Closed Access | Times Cited: 17
Xin He, Zhibing Weng, Yi Zou
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116096-116096
Closed Access | Times Cited: 17
PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer
Yulu Zhang, Annan Ming, Junyan Wang, et al.
Pharmacological Research (2024) Vol. 205, pp. 107234-107234
Open Access | Times Cited: 8
Yulu Zhang, Annan Ming, Junyan Wang, et al.
Pharmacological Research (2024) Vol. 205, pp. 107234-107234
Open Access | Times Cited: 8
Recent Progress in DNA Damage Response-Targeting PROTAC Degraders
Binbin Cheng, Xiaoting Fei, Zongbao Ding, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 6906-6921
Closed Access | Times Cited: 6
Binbin Cheng, Xiaoting Fei, Zongbao Ding, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 6906-6921
Closed Access | Times Cited: 6
The Quest for Oral PROTAC drugs: Evaluating the Weaknesses of the Screening Pipeline
Giulia Apprato, Giuseppe Ermondi, Giulia Caron
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 7, pp. 879-883
Open Access | Times Cited: 15
Giulia Apprato, Giuseppe Ermondi, Giulia Caron
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 7, pp. 879-883
Open Access | Times Cited: 15
Discovery of the GSH responsive “Y-PROTACs” targeting ALK and CDK4/6 as a potential treatment for cancer
Shirui Wang, Dan Luo, Chunlan Pu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115082-115082
Open Access | Times Cited: 14
Shirui Wang, Dan Luo, Chunlan Pu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115082-115082
Open Access | Times Cited: 14
Global research trends between gut microbiota and lung cancer from 2011 to 2022: A bibliometric and visualization analysis
Haitao Chen, YUEBIAO LAI, Chenxiao Ye, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Haitao Chen, YUEBIAO LAI, Chenxiao Ye, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Knowledge-Map Analysis of Undergraduate Biochemistry Teaching Research: A Bibliometric Study from 2012 to 2021
Yingmei He, Shan Li, Zongyun Chen, et al.
Journal of Chemical Education (2024) Vol. 101, Iss. 2, pp. 307-318
Closed Access | Times Cited: 4
Yingmei He, Shan Li, Zongyun Chen, et al.
Journal of Chemical Education (2024) Vol. 101, Iss. 2, pp. 307-318
Closed Access | Times Cited: 4
Exploring Research Trend and Hotspots on Oxidative Stress in Ischemic Stroke (2001–2022): Insights from Bibliometric
Nan Jiang, Ting Yang, Hongxia Han, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 6200-6216
Closed Access | Times Cited: 4
Nan Jiang, Ting Yang, Hongxia Han, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 6200-6216
Closed Access | Times Cited: 4
Combinatorial Ubiquitination REal-time PROteolysis (CURE-PROs): A Modular Platform for Generating Reversible, Self-Assembling Bifunctional Targeted Degraders
Sarah F. Giardina, Elena Valdambrini, Pradeep K. Singh, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5473-5501
Closed Access | Times Cited: 4
Sarah F. Giardina, Elena Valdambrini, Pradeep K. Singh, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5473-5501
Closed Access | Times Cited: 4
Mapping the Research Landscape on temporomandibular disorders and orthodontics treatment: A Bibliometric Analysis
Lulu Pan, Xueli Mao, Xi Ding, et al.
Journal of Stomatology Oral and Maxillofacial Surgery (2025), pp. 102212-102212
Closed Access
Lulu Pan, Xueli Mao, Xi Ding, et al.
Journal of Stomatology Oral and Maxillofacial Surgery (2025), pp. 102212-102212
Closed Access
Global hotspots and trends of nutritional supplements for sick populations from 2000 to 2024
Chaofan Shi, Haitao Liu, Te Fu, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Chaofan Shi, Haitao Liu, Te Fu, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Child marriage in high-prevalence countries: publication trends in SCI-E and SSCI journals and future recommendations
Zehra Koyuncu, Fatma Yağmur Evcil
Vulnerable Children and Youth Studies (2025), pp. 1-19
Closed Access
Zehra Koyuncu, Fatma Yağmur Evcil
Vulnerable Children and Youth Studies (2025), pp. 1-19
Closed Access
Bibliometric Insights Into Medical and Biological Sciences Research: A Case Study Approach
Arash Khaki
Crescent Journal of Medical and Biological Sciences (2025) Vol. 12, Iss. 1, pp. 1-2
Closed Access
Arash Khaki
Crescent Journal of Medical and Biological Sciences (2025) Vol. 12, Iss. 1, pp. 1-2
Closed Access
Minimal hepatic encephalopathy: a bibliometric analysis (1999–2023)
Chao Ju, Longtao Yang, Xuemei Wang, et al.
Current Psychology (2025)
Closed Access
Chao Ju, Longtao Yang, Xuemei Wang, et al.
Current Psychology (2025)
Closed Access
Visualization of Simulation-Based Training in Otolaryngology: A Bibliometric Analysis
Wenqi Yang, Xiaowei Zhang, Yuzhe Kong, et al.
Heliyon (2025) Vol. 11, Iss. 6, pp. e42678-e42678
Open Access
Wenqi Yang, Xiaowei Zhang, Yuzhe Kong, et al.
Heliyon (2025) Vol. 11, Iss. 6, pp. e42678-e42678
Open Access
Bibliometric and Visual Analysis of Alzheimer’s Disease and Herpes Simplex Virus Type 1 Infection Between 1990 and 2024
Hongling Ren, Ruiyao Song, Hairong Wang, et al.
Journal of Multidisciplinary Healthcare (2025) Vol. Volume 18, pp. 2097-2109
Open Access
Hongling Ren, Ruiyao Song, Hairong Wang, et al.
Journal of Multidisciplinary Healthcare (2025) Vol. Volume 18, pp. 2097-2109
Open Access
Discovery of a potent CDKs/FLT3 PROTAC with enhanced differentiation and proliferation inhibition for AML
Mingfei Wu, Wei Wang, Xinfei Mao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116539-116539
Closed Access | Times Cited: 3
Mingfei Wu, Wei Wang, Xinfei Mao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116539-116539
Closed Access | Times Cited: 3